Sequential Q4 Improvement and Full-Year Revenue Stability
Q4 returned to growth with +0.5% (Q4) and full-year revenue growth of +0.1% at constant currency and constant resin, finishing the year at EUR 3.25 billion and at the upper end of September guidance.
Aseptic Carton Growth and Capacity Expansion
Aseptic carton grew +1.2% with particularly strong performance in the Americas, supporting the decision to expand capacity at the Mexican production plant.
Filler Placement Activity within Target Range
Placed 68 new fillers in 2025, within the aspired range of 60-80 placements; incremental net growth in field fillers was +14 (54 returned/scrapped). Management expects a similar placement level in 2026.
Strong Innovation Momentum
Second Neo-line machine placed (Saudi Arabia) with very low waste rate (<0.5%) and capability for Alu-free full barrier sleeves; Terra Alu-free recognized as recyclable in Korea; DomeMini format to roll out in Europe H1 2026.
Sustainability Recognition
Received EcoVadis platinum status for the seventh time with a record score of 99/100.
Solid Adjusted Profitability (Excluding Nonrecurring Items)
Adjusted EBITDA excluding nonrecurring charges was EUR 788 million (margin 24.2%) and adjusted EBIT excluding nonrecurring charges was EUR 500 million (margin 15.7%). ROCE was 29% excluding nonrecurring charges.
Q4 Profitability and Cash Flow Strength
Q4 adjusted EBITDA was EUR 223 million (24.7% margin) including EUR 8.4m nonrecurring; excluding those charges, Q4 adjusted EBITDA was EUR 231 million (25.7% margin). Q4 free cash flow was EUR 275 million, close to prior year levels.
Clear 2026 and Midterm Guidance
2026 guidance: revenue growth flat to +2% (constant currency & resin), EBIT margin 15.7%-16.2%, tax rate 26%-28%, net CapEx 6%-8% of revenue. Midterm: revenue +3%-5%, EBIT >16.5%, target net leverage ~2x (milestone 2.5x by end-2027) and dividend payout corridor 30%-50% of adjusted net income.
Nonrecurring Charges Mostly Noncash and Within Guidance
Total nonrecurring pretax charges of EUR 351 million recorded in 2025 were within the previously communicated EUR 310-360m range and are ~90% noncash; expected cash impact in 2026 is ~EUR 25 million.
Working Capital and Interest Improvements
Net working capital improved by 100 basis points as a percentage of revenue due to lower accounts receivable; interest payments were lower by EUR 27 million (favorable bond timing and market rates).